The recent decline in rates is expected to enable more funding for clinical development initiatives, improving the outlook for CDMO companies.. (Source: Yeko Photo Studio for freepik)
The prospects for Indian CDMO companies are improving due to a rise in proposals from innovative pharmaceutical companies to non-Chinese companies.